Abstract
Melanoma and nonmelanoma skin cancer in children and adolescents are extremely rare, and the literature guiding the international pediatric medical community remains limited. The oncologic treatment of pediatric skin cancer continues to be extrapolated from the adult literature. A combination of biologic materials and advanced cosmetic reconstructive techniques continues to evolve in an attempt to achieve satisfactory oncologic outcomes while avoiding potentially disfiguring and catastrophic results. The purpose of this chapter is to comprehensively review the most prevalent cutaneous cancers affecting this pediatric population including melanoma, spitzoid melanoma, and squamous and basal cell carcinomas, in addition to the fundamental principles, techniques, and functional outcomes regarding cosmetic reconstruction surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balk SJ. Council on Environmental Health; Section on Dermatology. Ultraviolet radiation: a hazard to children and adolescents. Pediatrics. 2011;127(3):e791–817.
Senerchia AA, Ribeiro KB, Rodriguez-Galindo C. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study. Pediatr Blood Cancer. 2014;61(2):211–6.
Jung GW, Weinstock MA. Clinicopathological comparisons of index and second primary melanomas in paediatric and adult populations. Br J Dermatol. 2012;167(4):882–7.
Maguire-Eisen M. Skin cancer: a growing health problem for children. Semin Oncol Nurs. 2013;29(3):206–13.
Wong JR, Harris JK, Rodriguez-Galindo C, et al. Incidence of childhood and adolescent melanoma in the United States: 1973–2009. Pediatrics. 2013;131(5):846–54.
Baade PD, Youlden DR, Valery PC, et al. Trends in incidence of childhood cancer in Australia, 1983–2006. Br J Cancer. 2010;102(3):620–6.
Magnanti BL, Dorak MT, Parker L, et al. Sex-specific incidence and temporal trends in solid tumours in young people from Northern England, 1968–2005. BMC Cancer. 2008;8:89.
de Vries E, Steliarova-Foucher E, Spatz A. Skin cancer incidence and survival in European children and adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2170–82.
Ferrari A, Bisogno G, Cecchetto G, et al. Cutaneous melanoma in children and adolescents: the Italian rare tumors in pediatric age project experience. J Pediatr. 2014;164(2):376–382.e1-2.
Handfield-Jones SE, Smith NP. Malignant melanoma in childhood. Br J Dermatol. 1996;134(4):607–16.
Hamm H, Höger PH. Skin tumors in childhood. Dtsch Arztebl Int. 2011;108(20):347–53.
Children’s Oncology Group (COG). Melanoma. Available at: www.childrensoncologygroup.org/index/melanoma. Accessed 30 May 2014
Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23(21):4735–41.
Austin MT, Xing Y, Hayes-Jordan AA, et al. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States. J Pediatr Surg. 2013;48(11):2207–13.
Hawryluk EB, Liang MG. Pediatric melanoma, moles, and sun safety. Pediatr Clin North Am. 2014;61(2):279–91.
Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107(7 Suppl):1645–55.
Reed D, Kudchadkar R, Zager JS, et al. Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults. J Natl Compr Canc Netw. 2013;11(6):679–86.
Chao MM, Schwartz JL, Wechsler DS, et al. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatr Blood Cancer. 2005;44(5):441–8.
Moscarella E, Zalaudek I, Cerroni L, et al. Excised melanocytic lesions in children and adolescents: a 10-year survey. Br J Dermatol. 2012;167(2):368–73.
Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med. 1995;332(10):656–62.
Mones JM, Ackerman AB. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol. 2003;25(3):223–38.
Downard CD, Rapkin LB, Gow KW. Melanoma in children and adolescents. Surg Oncol. 2007;16(3):215–20.
Mills O, Messina JL. Pediatric melanoma: a review. Cancer Control. 2009;16(3):225–33.
Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39(18):2651–61.
Neier M, Pappo A, Navid F. Management of melanomas in children and young adults. J Pediatr Hematol Oncol. 2012;34(Suppl 2):S51–4.
Braam KI, Overbeek A, Kaspers GJ. Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: a systematic review. Pediatr Blood Cancer. 2012;58(5):665–74.
National Cancer Institute at the National Institutes of Health. Melanoma (PDQ®). Available at: http://www.cancer.gov. Accessed 30 May 2014
Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol. 2004;195(3):298–308.
Godar DE, Urbach F, Gasparro FP. UV doses of young adults. Photochem Photobiol. 2003;77(4):453–7.
D’Orazio J, Jarrett S, Amaro-Ortiz A. UV radiation and the skin. Int J Mol Sci. 2013;14(6):12222–48.
Geller AC, Colditz G, Oliveria S. Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics. 2002;109(6):1009–14.
Lazovich D, Vogel RI, Berwick M. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1557–68.
Meyskens FL Jr, Farmer P, Fruehauf JP. Redox regulation in human melanocytes and melanoma. Pigment Cell Res. 2001;14(3):148–54.
Corona R, Mele A, Amini M. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol. 1996;14(4):1218–23.
Ito S, Wakamatsu K. Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment Cell Res. 2003;16(5):523–31.
Uribe P, Wistuba II, Solar A. Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma. Am J Dermatopathol. 2005;27(4):279–85.
Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130–51.
Cordoro KM, Gupta D, Frieden IJ. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J Am Acad Dermatol. 2013;68(6):913–25.
Slade AD, Austin MT. Childhood melanoma: an increasingly important health problem in the USA. Curr Opin Pediatr. 2014;26(3):356–61.
Balch CM, Gershenwald JE, Soong SJ. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.
Pollock PM, Meltzer PS. A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell. 2002;2(1):5–7.
Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.
Livestro DP, Kaine EM, Michaelson JS. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110(3):614–24.
Lewis KG. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg. 2008;34(2):152–9.
Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115(3):649–54.
Lange JR, Balch CM. Melanoma in children: heightened awareness of an uncommon but often curable malignancy. Pediatrics. 2005;115(3):802–3.
Moore-Olufemi S, Herzog C, Warneke C, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011;253(6):1211–5.
Mu E, Lange JR, Strouse JJ. Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. Cancer. 2012;118(10):2700–7.
Navid F, Furman WL, Fleming M, et al. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer. 2005;103(4):780–7.
Spitz S. Melanomas of childhood. Am J Pathol. 1948;24(3):591–609.
Casso EM, Grin-Jorgensen CM, Grant-Kels JM. Spitz nevi. J Am Acad Dermatol. 1992;27:901–13.
Tom WL, Hsu JW, Eichenfield LF, et al. Pediatric “STUMP” lesions: evaluation and management of difficult atypical Spitzoid lesions in children. J Am Acad Dermatol. 2011;64(3):559–72.
Miteva M, Lazova R. Spitz nevus and atypical spitzoid neoplasm. Semin Cutan Med Surg. 2010;29(3):165–73.
Wititsuwannakul J, Mason AR, Klump VR, et al. Neuropilin-2 as a useful marker in the differentiation between Spitzoid malignant melanoma and Spitz nevus. J Am Acad Dermatol. 2013;68(1):129–37.
Kirkwood JM, Jukic DM, Averbook BJ, et al. Melanoma in pediatric, adolescent, and young adult patients. Semin Oncol. 2009;36(5):419–31.
Schmoeckel C, Wildi G, Schäfer T. Spitz nevus versus malignant melanoma: spitz nevi predominate on the thighs in patients younger than 40 years of age, melanomas on the trunk in patients 40 years of age or older. J Am Acad Dermatol. 2007;56(5):753–8.
Pratt CB, Palmer MK, Thatcher N, et al. Malignant melanoma in children and adolescents. Cancer. 1981;47(2):392–7.
Ferrara G, Argenziano G, Soyer HP, et al. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol. 2005;141(11):1381–7.
Marghoob AA. Practice gaps. Underuse of dermoscopy in assessing Spitz nevi in children: comment on “Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists”. JAMA Dermatol. 2013;149(3):291–2.
Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol. 2006;19(Suppl 2):S21–33.
Massi G. Melanocytic nevi simulant of melanoma with medicolegal relevance. Virchows Arch. 2007;451(3):623–47.
Elder DE, Murphy GF. Spindle and epithelioid cell melanocytic tumors/nevi in melanocytic tumors of the skin. In: AFIP atlas of tumor pathology, 4th series, fascicle 12. Washington, DC: American Registry of Pathology; 2010. p. 83–114.
Crotty KA, Scolyer RA, Li L, et al. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology. 2002;34(1):6–12.
Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30(5):513–20.
Barnhill RL. The spitzoid lesion: the importance of atypical variants and risk assessment. Am J Dermatopathol. 2006;28(1):75–83.
McNutt NS, Urmacher C, Hakimian J, et al. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol. 1995;22(6):502–17.
Smith KJ, Barrett TL, Skelton HG 3rd, et al. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989;13(11):931–9.
Palazzo J, Duray PH. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study. Hum Pathol. 1989;20(4):341–6.
Bergman R, Shemer A, Levy R, et al. Immunohistochemical study of p53 protein expression in Spitz nevus as compared with other melanocytic lesions. Am J Dermatopathol. 1995;17(6):547–50.
Bergman R, Dromi R, Trau H, et al. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol. 1995;17(6):542–6.
Ribé A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol. 2003;16(5):505–11.
Kanter-Lewensohn L, Hedblad MA, Wejde J, et al. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol. 1997;10(9):917–20.
Li LX, Crotty KA, McCarthy SW, et al. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol. 2000;22(6):489–95.
Bergman R, Malkin L, Sabo E, et al. MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol. 2001;44(3):500–4.
Niemann TH, Argenyi ZB. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen. Am J Dermatopathol. 1993;15(5):441–5.
Tu P, Miyauchi S, Miki Y. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate. Am J Dermatopathol. 1993;15(4):311–4.
Kapur P, Selim MA, Roy LC, et al. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol. 2005;18(2):197–204.
Nagasaka T, Lai R, Medeiros LJ, et al. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study. Am J Dermatopathol. 1999;21(2):115–20.
Innocenzi D, Alò PL, Balzani A, et al. Fatty acid synthase expression in melanoma. J Cutan Pathol. 2003;30(1):23–8.
Kaleem Z, Lind AC, Humphrey PA, et al. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? Mod Pathol. 2000;13(3):217–22.
Sparrow LE, Eldon MJ, English DR, et al. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry. Am J Dermatopathol. 1998;20:255–61.
George E, Polissar NL, Wick M. Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors. Am J Clin Pathol. 2010;133:370–9.
Al Dhaybi R, Agoumi M, Gagne I, et al. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. J Am Acad Dermatol. 2011;65:357–63.
Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells. 2008;26(12):3008–17.
Al Dhaybi R, Sartelet H, Powell J, et al. Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol. 2010;23(3):376–80.
King MS, Porchia SJ, Hiatt KM. Differentiating Spitzoid melanomas from Spitz nevi through CD99 expression. J Cutan Pathol. 2007;34:576–80.
Wilkerson AE, Glasgow MA, Hiatt KM. Immunoreactivity of CD99 in invasive malignant melanoma. J Cutan Pathol. 2006;33(10):663–6.
Ingves C, Jemec GB. Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma. Scand J Plast Reconstr Surg Hand Surg. 2003;37(5):293–5.
National Cancer Institute at the National Institutes of Health. Nonmelanoma skin cancer (PDQ®). Available at: http://www.cancer.gov. Accessed 30 May 2014
de la Luz Orozco-Covarrubias M, Tamayo-Sanchez L, Duran-McKinster C, et al. Malignant cutaneous tumors in children. Twenty years of experience at a large pediatric hospital. J Am Acad Dermatol. 1994;30(2 Pt 1):243–9.
Kuvat SV, Gücin Z, Keklik B, et al. Basal cell carcinoma in a child. J Skin Cancer. 2011:752901.
Sasson M, Mallory SB. Malignant primary skin tumors in children. Curr Opin Pediatr. 1996;8(4):372–7.
Efron PA, Chen MK, Glavin FL, et al. Pediatric basal cell carcinoma: case reports and literature review. J Pediatr Surg. 2008;43(12):2277–80.
Awan BA, Alzanbagi H, Samargandi OA, et al. Scalp squamous cell carcinoma in xeroderma pigmentosum. N Am J Med Sci. 2014;6(2):105–6.
Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48(3):168–76.
Roozeboom MH, Lohman BG, Westers-Attema A, et al. Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a defined population. Acta Derm Venereol. 2013;93(4):417–21.
Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;106(11):2389–96.
Ramirez CC, Federman DG, Kirsner RS. Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol. 2005;44(2):95–100.
Reszko A, Aasi SZ, Wilson LD, et al. Cancer of the skin. In: De Vita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 1610–33.
Ping XL, Ratner D, Zhang H, et al. PTCH mutations in squamous cell carcinoma of the skin. J Invest Dermatol. 2001;116(4):614–6.
Byrd DR, Compton CC, et al. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Edge SB, editor. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010. p. 301–14.
Posso-De Los Rios CJ, Lara-Corrales I, Ho N. Dermatofibrosarcoma protuberans in pediatric patients: a report of 17 cases. J Cutan Med Surg. 2014;18(3):180–5.
Jafarian F, McCuaig C, Kokta V, et al. Dermatofibrosarcoma protuberans in childhood and adolescence: report of eight patients. Pediatr Dermatol. 2008;25(3):317–25.
Cottel WI, Proper S. Mohs’ surgery, fresh-tissue technique. Our technique with a review. J Dermatol Surg Oncol. 1982;8(7):576–87.
Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27(2. Pt 1):241–8.
Ratner D. Skin grafting. From here to there. Dermatol Clin. 1998;16(1):75–9.
Earle SA, Marshall DM. Management of giant congenital nevi with artificial skin substitutes in children. J Craniofac Surg. 2005;16(5):904–7.
Burke JF, Yannas IV, Quinby WC. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg. 1981;194:413–28.
Moiemen NS, Staiano JJ, Ojeh NO, et al. Reconstructive surgery with a dermal regeneration template: clinical and histologic study. Plast Reconstr Surg. 2001;108(1):93–103.
Abai B, Thayer D, Glat PM. The use of a dermal regeneration template (Integra) for acute resurfacing and reconstruction of defects created by excision of giant hairy nevi. Plast Reconstr Surg. 2004;114:162–8.
Fang P, Engrav LH, Gibran NS, et al. Dermatome setting for autografts to cover Integra. J Burn Care Rehabil. 2002;23:327–32.
Chou TD, Chen SL, Lee TW, et al. Reconstruction of burn scar of the upper extremities with artificial skin. Plast Reconstr Surg. 2001;108:378–84.
Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg. 2001;54:659–64.
Stiefel D, Schiestl CM, Meuli M. The positive effect of negative pressure: vacuum-assisted fixation of Integra artificial skin for reconstructive surgery. J Pediatr Surg. 2009;44(3):575–80.
Kayser M. Surgical flaps. SRPS. 1999;9(2):1–63.
Carriquiry C, Costa MA, Vasconez LO. An anatomic study of the septocutaneous vessels of the leg. Plast Reconstr Surg. 1985;76:354–63.
Lin CH, Mardini S, Wei FC, et al. Free flap reconstruction of foot and ankle defects in pediatric patients: long-term outcome in 91 cases. Plast Reconstr Surg. 2006;117(7):2478–87.
Upton J, Guo L, Labow BI. Pediatric free-tissue transfer. Plast Reconstr Surg. 2009;124(6 Suppl):e313–26.
Van Landuyt K, Hamdi M, Blondeel P, et al. Free perforator flaps in children. Plast Reconstr Surg. 2005;116:159–69.
Hurvitz KA, Rosen H, Meara JG. Pediatric cervicofacial tissue expansion. Int J Pediatr Otorhinolaryngol. 2005;69(11):1509–13.
Radovan C. Tissue expansion in soft-tissue reconstruction. Plast Reconstr Surg. 1984;74:482–92.
Vergnes P, Taieb A, Maleville J, et al. Repeated skin expansion for excision of congenital giant nevi in infancy and childhood. Plast Reconstr Surg. 1993;91:450–5.
Bauer BS, Vicari FA, Richard ME. The role of tissue expansion in pediatric plastic surgery. Clin Plast Surg. 1990;17:101–12.
Adler N, Dorafshar AH, Bauer BS, et al. Tissue expander infections in pediatric patients: management and outcomes. Plast Reconstr Surg. 2009;124(2):484–9.
Han D, Zager JS, Han G, et al. The unique clinical characteristics of melanoma diagnosed in children. Ann Surg Oncol. 2012;19(12):3888–95.
National Cancer Institute at the National Institutes of Health. Skin Cancer Treatment (PDQ®). Available at: http://www.cancer.gov. Accessed May 30, 2014.
Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–28. Review
LeSueur BW, Silvis NG, Hansen RC. Basal cell carcinoma in children: report of 3 cases. Arch Dermatol. 2000;136(3):370–2. Review
Turner CD, Shea CR, Rosoff PM. Basal cell carcinoma originating from a nevus sebaceus on the scalp of a 7-year-old boy. J Pediatr Hematol Oncol. 2001;23(4):247–9.
Motley R, Kersey P, Lawrence C. British Association of Dermatologists; British Association of Plastic Surgeons; Royal College of Radiologists, Faculty of Clinical Oncology. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002;146(1):18–25.
Varan A, Gököz A, Akyüz C, et al. Primary malignant skin tumors in children: etiology, treatment and prognosis. Pediatr Int. 2005;47(6):653–7.
Terzis JK, Konofaos P. Experience with 60 adult patients with facial paralysis secondary to tumor extirpation. Plast Reconstr Surg. 2012;130(1):51e–66e.
Terzis JK, Konofaos P. Reanimation of facial palsy following tumor extirpation in pediatric patients: our experience with 16 patients. J Plast Reconstr Aesthet Surg. 2013;66(9):1219–29.
Pajulo OT, Pulkki KJ, Alanen MS, et al. Duration of surgery and patient age affect wound healing in children. Wound Repair Regen. 2000;8:174–8.
Hogg NJ. Primary and secondary management of pediatric soft tissue injuries. Oral Maxillofac Surg Clin North Am. 2012;24(3):365–75.
Kung TA, Gosain AK. Pediatric facial burns. J Craniofac Surg. 2008;19:951–9.
Tsao SS, Dover JS, Arndt KA. Scar management: keloid, hypertrophic, atrophic and acne scars. Semin Cutan Med Surg. 2002;21:46–55.
Arnez ZM, Hanel DP. Free tissue transfer for reconstruction of traumatic limb injuries in children. Microsurgery. 1991;12:207–15.
Konttila E, Koljonen V, Kauhanen S, et al. Microvascular reconstruction in children-a report of 46 cases. J Trauma. 2010;68(3):548–52.
Friedman RM, Ingram AE, Rohrich RJ, et al. Risk factors for complications in pediatric tissue expansion. Plast Reconstr Surg. 1996;98:1242–6.
Pisarski GP, Mertens D, Warden GD, et al. Tissue expander complications in the pediatric burn patient. Plast Reconstr Surg. 1998;102:1008–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Malkan, A.D., Konofaos, P., Wallace, R.D., Sandoval, J.A. (2020). Nonmelanoma Skin Cancer and Cutaneous Melanoma in the Pediatric Population. In: Papadopoulos, O., Papadopulos, N.A., Champsas, G. (eds) Non-Melanoma Skin Cancer and Cutaneous Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-030-18797-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-18797-2_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18795-8
Online ISBN: 978-3-030-18797-2
eBook Packages: MedicineMedicine (R0)